CD8A and infection: Following infection, anti-CD3 antibody treated animals showed markedly enhanced bioluminescence compared to untreated or anti-CD4 antibody treated CD8-/-JHT mice at days 7 and 9 p.i., indicating loss of control of virus replication (Fig. 1A).